Strides Shasun gets USFDA nod for altitude sickness tablets Ruby Khatun Khatun23 Nov 2017 10:30 AM ISTBangalore: Strides Shasun Limited announced that it's wholly owned subsidiary Strides Pharma Global Pte. Ltd. has received approval from the United...
Ajanta Pharma launches generic ADHD treatment drug in US Ruby Khatun Khatun23 Nov 2017 10:15 AM ISTNew Delhi: Drug firm Ajanta Pharma said it has launched generic Clonidine Hydrochloride extended-release tablets in the American market after...
Dr Reddy's gets EIR for Vizag plant, but inspection not closed Ruby Khatun Khatun22 Nov 2017 11:06 AM ISTNew Delhi: Dr. Reddy's Laboratories said it has received an establishment inspection report (EIR) from the US health regulator for its formulation...
Glenmark gets USFDA nod for contraceptive tablets Ruby Khatun Khatun22 Nov 2017 10:30 AM ISTNew Delhi: Glenmark Pharmaceuticals has received final approval from the US health regulator for the generic version of Loestrin tablets used to...
Divis Lab Vizag unit gets USFDA EIR with 6 observations Ruby Khatun Khatun20 Nov 2017 10:45 AM ISTNew Delhi: Drug firm Divis Laboratories on Saturday said it has received an establishment inspection report (EIR) from the US health regulator for its...
Zydus Cadila gets USFDA nod for swelling reducing drug Ruby Khatun Khatun20 Nov 2017 10:02 AM ISTNew Delhi: Zydus Cadila has received final approval from the US health regulator to market Ethacrynate sodium for injection, used to reduce swelling...
Lupin gets warning letter from USFDA for Goa, Indore plants Ruby Khatun Khatun17 Nov 2017 11:00 AM ISTNew Delhi: The US Food and Drug Administration (USFDA) has issued a warning letter to Lupin for violation of current good manufacturing practice norms...
Cipla gets USFDA nod for generic version of Renvela tablets supriya kashyap kashyap28 Oct 2017 9:18 AM ISTNew Delhi: Drug major Cipla said its subsidiary InvaGen Pharmaceuticals Inc has received final approval from the US health regulator for Sevelamer...
Granules India gets EIR from USFDA for Vizag OmniChem facility Ruby Khatun Khatun8 Oct 2017 10:01 AM ISTNew Delhi: Drug firm Granules India said it has received Establishment Inspection Report (EIR) from the US health regulator for the OmniChem facility...
Zydus gets USFDA nod for overactive bladder drug Ruby Khatun Khatun6 Oct 2017 9:49 AM ISTNew Delhi: Drug firm Zydus Cadila said it has received final approval from the US health regulator to market capsules used in treating overactive...
Zydus gets USFDA nod to market anti-diuretic nasal spray Ruby Khatun Khatun5 Oct 2017 10:17 AM ISTNew Delhi: Drug firm Zydus Cadila said it has received final approval from the US health regulator to market anti-diuretic Desmopressin nasal spray...
Lupin gets USFDA nod for generic version of Clobex lotion Ruby Khatun Khatun27 Sept 2017 12:43 PM ISTNew Delhi: Drug maker Lupin said it has received approval from the US health regulator to market anti-inflammatory Clobetasol Propionate lotion in the...
